Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Katzenellenbogen

Showing results (61-70 of 277) with videos related to

Pageof 28
Sort By:
Nuclear Medicine and Biology|October 4, 2022
Solid phase radiosynthesis of an olaparib derivative using 4-[<sup>18</sup>F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expressionJinbin Xu, Huaping Chen, Buck E Rogers, et al.
Endocrinology|March 23, 2004
Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradationHoung-Wei Tsai, John A Katzenellenbogen, Benita S Katzenellenbogen, et al.
ACS Chemical Biology|May 20, 2008
Amphipathic benzenes are designed inhibitors of the estrogen receptor alpha/steroid receptor coactivator interactionJillian R Gunther, Terry W Moore, Margaret L Collins, et al.
Bioorganic & Medicinal Chemistry|November 4, 2008
Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptorAndrew L LaFrate, Jillian R Gunther, Kathryn E Carlson, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 18, 2017
Evaluation of aromatic radiobromination by nucleophilic substitution using diaryliodonium salt precursorsDong Zhou, Sung Hoon Kim, Wenhua Chu, et al.
Hormones and Behavior|September 7, 2010
Impact of estrogen receptor alpha and beta agonists on delayed alternation in middle-aged ratsSteven L Neese, Donna L Korol, John A Katzenellenbogen, et al.
The Journal of Organic Chemistry|October 25, 2001
Synthesis of 2-[(18)F]Fluoroestradiol, a Potential Diagnostic Imaging Agent for Breast Cancer: Strategies to Achieve Nucleophilic Substitution of an Electron-Rich Aromatic Ring with [(18)F]F(-)Eric D. Hostetler, Stephanie D. Jonson, Michael J. Welch, et al.
Analytical Chemistry|October 14, 2015
Fluorescent Nanoconjugate Derivatives with Enhanced Photostability for Single Molecule ImagingDaniel T Reilly, Sung Hoon Kim, John A Katzenellenbogen, et al.
Nuclear Medicine and Biology|May 28, 2003
Synthesis and biological evaluation of a fluorine-18 labeled estrogen receptor-alpha selective ligand: [18F] propyl pyrazole triolDange Vijaykumar, Mohammed H Al-Qahtani, Michael J Welch, et al.
Molecular Endocrinology (Baltimore, Md.)|September 2, 2006
Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activityVarsha S Likhite, Fabio Stossi, Kyuri Kim, et al.
Pageof 28

Showing results (61-70 of 277) with videos related to

Sort By:
Pageof 28
Nuclear Medicine and Biology|October 4, 2022
Solid phase radiosynthesis of an olaparib derivative using 4-[<sup>18</sup>F] fluorobenzoic acid and in vivo evaluation in breast and prostate cancer xenograft models for PARP-1 expressionJinbin Xu, Huaping Chen, Buck E Rogers, et al.
Endocrinology|March 23, 2004
Protein kinase A activation of estrogen receptor alpha transcription does not require proteasome activity and protects the receptor from ligand-mediated degradationHoung-Wei Tsai, John A Katzenellenbogen, Benita S Katzenellenbogen, et al.
ACS Chemical Biology|May 20, 2008
Amphipathic benzenes are designed inhibitors of the estrogen receptor alpha/steroid receptor coactivator interactionJillian R Gunther, Terry W Moore, Margaret L Collins, et al.
Bioorganic & Medicinal Chemistry|November 4, 2008
Synthesis and biological evaluation of guanylhydrazone coactivator binding inhibitors for the estrogen receptorAndrew L LaFrate, Jillian R Gunther, Kathryn E Carlson, et al.
Journal of Labelled Compounds & Radiopharmaceuticals|May 18, 2017
Evaluation of aromatic radiobromination by nucleophilic substitution using diaryliodonium salt precursorsDong Zhou, Sung Hoon Kim, Wenhua Chu, et al.
Hormones and Behavior|September 7, 2010
Impact of estrogen receptor alpha and beta agonists on delayed alternation in middle-aged ratsSteven L Neese, Donna L Korol, John A Katzenellenbogen, et al.
The Journal of Organic Chemistry|October 25, 2001
Synthesis of 2-[(18)F]Fluoroestradiol, a Potential Diagnostic Imaging Agent for Breast Cancer: Strategies to Achieve Nucleophilic Substitution of an Electron-Rich Aromatic Ring with [(18)F]F(-)Eric D. Hostetler, Stephanie D. Jonson, Michael J. Welch, et al.
Analytical Chemistry|October 14, 2015
Fluorescent Nanoconjugate Derivatives with Enhanced Photostability for Single Molecule ImagingDaniel T Reilly, Sung Hoon Kim, John A Katzenellenbogen, et al.
Nuclear Medicine and Biology|May 28, 2003
Synthesis and biological evaluation of a fluorine-18 labeled estrogen receptor-alpha selective ligand: [18F] propyl pyrazole triolDange Vijaykumar, Mohammed H Al-Qahtani, Michael J Welch, et al.
Molecular Endocrinology (Baltimore, Md.)|September 2, 2006
Kinase-specific phosphorylation of the estrogen receptor changes receptor interactions with ligand, deoxyribonucleic acid, and coregulators associated with alterations in estrogen and tamoxifen activityVarsha S Likhite, Fabio Stossi, Kyuri Kim, et al.
Pageof 28